» Articles » PMID: 37700862

Recent Advances in Microbiological and Molecular Biological Detection Techniques of Tuberculous Meningitis

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2023 Sep 13
PMID 37700862
Authors
Affiliations
Soon will be listed here.
Abstract

Tuberculous meningitis (TBM) is the most common type of central nervous system tuberculosis (TB) and has the highest mortality and disability rate. Early diagnosis is key to improving the prognosis and survival rate of patients. However, laboratory diagnosis of TBM is often difficult due to its paucibacillary nature and sub optimal sensitivity of conventional microbiology and molecular tools which often fails to detect the pathogen. The gold standard for TBM diagnosis is the presence of MTB in the CSF. The recognised methods for the identification of MTB are acid-fast bacilli (AFB) detected under CSF smear microscopy, MTB cultured in CSF, and MTB detected by polymerase chain reaction (PCR). Currently, many studies consider that all diagnostic techniques for TBM are not perfect, and no single technique is considered simple, fast, cheap, and efficient. A definite diagnosis of TBM is still difficult in current clinical practice. In this review, we summarise the current state of microbiological and molecular biological diagnostics for TBM, the latest advances in research, and discuss the advantages of these techniques, as well as the issues and challenges faced in terms of diagnostic effectiveness, laboratory infrastructure, testing costs, and clinical expertise, for clinicians to select appropriate testing methods.

Citing Articles

Utility of Cerebrospinal Fluid Unstimulated Interferon-Gamma (IRISA-TB) as a Same-Day Test for Tuberculous Meningitis in a Tuberculosis-Endemic, Resource-Poor Setting.

Randall P, Mutsvangwa J, Nliwasa M, Wilson L, Makamure B, Makambwa E Open Forum Infect Dis. 2024; 11(9):ofae496.

PMID: 39286031 PMC: 11403475. DOI: 10.1093/ofid/ofae496.


The value of nanopore sequencing as a diagnostic tool in tuberculous meningitis: A protocol of systematic review and meta-analysis.

Shen Y, Ling Y, Yu G, Zhang X PLoS One. 2024; 19(7):e0307389.

PMID: 39024305 PMC: 11257307. DOI: 10.1371/journal.pone.0307389.


The application value of cerebrospinal fluid immunoglobulin in tuberculous meningitis.

He H, Xu J, Peng Q, Li Y, Huang Y, Zhang Y Microbiol Spectr. 2024; 12(6):e0015724.

PMID: 38666897 PMC: 11237685. DOI: 10.1128/spectrum.00157-24.

References
1.
Ahlawat S, Chaudhary R, Dangi M, Bala K, Singh M, Chhillar A . Advances in tuberculous meningitis diagnosis. Expert Rev Mol Diagn. 2020; 20(12):1229-1241. DOI: 10.1080/14737159.2020.1858805. View

2.
Khonga M, Nicol M . Xpert MTB/RIF Ultra: a gamechanger for tuberculous meningitis?. Lancet Infect Dis. 2017; 18(1):6-8. DOI: 10.1016/S1473-3099(17)30536-4. View

3.
Bahr N, Tugume L, Rajasingham R, Kiggundu R, Williams D, Morawski B . Improved diagnostic sensitivity for tuberculous meningitis with Xpert(®) MTB/RIF of centrifuged CSF. Int J Tuberc Lung Dis. 2015; 19(10):1209-15. PMC: 4768484. DOI: 10.5588/ijtld.15.0253. View

4.
Shao L, Qiu C, Zheng L, Yang Y, Yang X, Liang Q . Comparison of diagnostic accuracy of the GeneXpert Ultra and cell-free nucleic acid assay for tuberculous meningitis: A multicentre prospective study. Int J Infect Dis. 2020; 98:441-446. DOI: 10.1016/j.ijid.2020.06.076. View

5.
Selvakumar N, Vanajakumar , Thilothammal N, Paramasivan C . Isolation of Mycobacterium tuberculosis from cerebrospinal fluid by the centrifugation & filtration methods. Indian J Med Res. 1996; 103:250-2. View